D-0305-2025 Class III Ongoing

Recalled by Imprimis NJOF, LLC — Ledgewood, NJ

FDA drug recall D-0305-2025 was initiated by Imprimis NJOF, LLC on Feb 24, 2025 and is designated Class III. Reason for recall: Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim. The recall status is ongoing. Affected quantity: 2822 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 9, 2025
Initiation Date
Feb 24, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2822 bottles

Product description

Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.

Reason for recall

Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.

Distribution pattern

FL and NY

Code information

Lot 24OCT041, Exp 04/26/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0305-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0305-2025. Report a data issue: hello@regdatalab.com.